The Path to Clinical Protocols

FEATUREIslet Transplantation The Path to Clinical ProtocolsARTICLE EXTRASRelated Articles: Transplanting ISLETS for DiabetesHow to overcome the remaining hurdles in cell survival, supply, and immune rejection©1982 AMERICAN DIABETES ASSOCIATIONThe Edmonton Protocol and its more recent improvements are the product of incremental contributions made during the past 34 years. Paul E. Lacy first

The Scientist Staff
May 1, 2006
FEATURE
Islet Transplantation

The Path to Clinical Protocols

©1982 AMERICAN DIABETES ASSOCIATION

The Edmonton Protocol and its more recent improvements are the product of incremental contributions made during the past 34 years. Paul E. Lacy first extracted islets from the rat pancreas with the enzyme collagenase, and used the islets to reverse diabetes in 1972.1 These tantalizing results in rodents left the distinct impression that islet-replacement therapy was a mere step away from the clinic. But extracting large numbers of healthy islets from the more fibrous human pancreas proved exceedingly difficult. Early attempts with unpurified pancreatic digests occasionally led to disaster.

Fatal portal vein thrombosis, portal hypertension, and disseminated intravascular coagulation were among the outcomes. Fortunately, islets have a lower osmotic density than the exocrine tissue, and that...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?